HUP0001796A3 - Dipeptide benzamidine as a kininogenase inhibitor and pharmaceutical compositions containing them - Google Patents
Dipeptide benzamidine as a kininogenase inhibitor and pharmaceutical compositions containing themInfo
- Publication number
- HUP0001796A3 HUP0001796A3 HU0001796A HUP0001796A HUP0001796A3 HU P0001796 A3 HUP0001796 A3 HU P0001796A3 HU 0001796 A HU0001796 A HU 0001796A HU P0001796 A HUP0001796 A HU P0001796A HU P0001796 A3 HUP0001796 A3 HU P0001796A3
- Authority
- HU
- Hungary
- Prior art keywords
- benzamidine
- dipeptide
- pharmaceutical compositions
- compositions containing
- kininogenase inhibitor
- Prior art date
Links
- 108010016626 Dipeptides Proteins 0.000 title 1
- 102000001399 Kallikrein Human genes 0.000 title 1
- 108060005987 Kallikrein Proteins 0.000 title 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940039088 kininogenase Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19632772A DE19632772A1 (de) | 1996-08-14 | 1996-08-14 | Neue Benzamidine |
| PCT/EP1997/004105 WO1998006740A1 (de) | 1996-08-14 | 1997-07-29 | Dipeptidische benzamidine als kininogenasen-inhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0001796A2 HUP0001796A2 (hu) | 2000-11-28 |
| HUP0001796A3 true HUP0001796A3 (en) | 2001-12-28 |
Family
ID=7802623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001796A HUP0001796A3 (en) | 1996-08-14 | 1997-07-29 | Dipeptide benzamidine as a kininogenase inhibitor and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6440937B1 (hu) |
| EP (1) | EP0918792B1 (hu) |
| JP (1) | JP2000517300A (hu) |
| KR (1) | KR20000030004A (hu) |
| CN (1) | CN1233256A (hu) |
| AT (1) | ATE196637T1 (hu) |
| AU (1) | AU717692B2 (hu) |
| BR (1) | BR9711134A (hu) |
| CA (1) | CA2263344A1 (hu) |
| CZ (1) | CZ31199A3 (hu) |
| DE (2) | DE19632772A1 (hu) |
| ES (1) | ES2151741T3 (hu) |
| HU (1) | HUP0001796A3 (hu) |
| IL (1) | IL128231A0 (hu) |
| NO (1) | NO990667L (hu) |
| TW (1) | TW442471B (hu) |
| WO (1) | WO1998006740A1 (hu) |
| ZA (1) | ZA977240B (hu) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602263D0 (sv) | 1996-06-07 | 1996-06-07 | Astra Ab | New amino acid derivatives |
| SE9602646D0 (sv) | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
| AR013084A1 (es) | 1997-06-19 | 2000-12-13 | Astrazeneca Ab | Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados |
| SE9704543D0 (sv) | 1997-12-05 | 1997-12-05 | Astra Ab | New compounds |
| WO1999064392A1 (fr) | 1998-06-08 | 1999-12-16 | Ajinomoto Co., Inc. | Derive de benzamidine |
| SE9804313D0 (sv) | 1998-12-14 | 1998-12-14 | Astra Ab | New compounds |
| AU764121B2 (en) | 1999-01-13 | 2003-08-07 | Astrazeneca Ab | New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| JP4489976B2 (ja) * | 1999-04-09 | 2010-06-23 | ビーエーエスエフ ソシエタス・ヨーロピア | 補体プロテアーゼの低分子インヒビター |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| SE0001803D0 (sv) | 2000-05-16 | 2000-05-16 | Astrazeneca Ab | New compounds i |
| US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
| DE10049937A1 (de) * | 2000-10-06 | 2002-04-11 | Knoll Ag | Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
| DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
| DE10117730A1 (de) * | 2001-04-09 | 2002-10-10 | Basf Ag | Umsetzung von (Di)Aminen in Gegenwart einer Lysinoxidase und eines Reduktionsmittels |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| US6849084B2 (en) * | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
| US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| EP1736465A4 (en) * | 2004-03-31 | 2009-06-17 | Ajinomoto Kk | ANILINE DERIVATIVES |
| US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
| TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
| US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
| CA3168591A1 (en) | 2010-01-06 | 2011-07-14 | Takeda Pharmaceutical Company Limited | Plasma kallikrein binding proteins |
| JP2014506257A (ja) * | 2011-01-06 | 2014-03-13 | ダイアックス コーポレーション | 血漿カリクレイン結合タンパク質 |
| JP2016513682A (ja) | 2013-03-15 | 2016-05-16 | ダイアックス コーポレーション | 抗血漿カリクレイン抗体 |
| ES2856076T3 (es) | 2014-01-21 | 2021-09-27 | Takeda Pharmaceuticals Co | Proteínas de unión a calicreína plasmática y usos de las mismas en el tratamiento de angioedema hereditario |
| KR102555955B1 (ko) | 2014-03-27 | 2023-07-18 | 다케다 파머수티컬 컴패니 리미티드 | 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법 |
| EP3387018A1 (en) | 2015-12-11 | 2018-10-17 | Dyax Corp. | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU675981B2 (en) | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
| SE9301916D0 (sv) | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| DE4421052A1 (de) | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| BR9607582A (pt) | 1995-02-17 | 1998-07-07 | Basf Ag | Composto e peptídeo ou substância peptidomimética |
| DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
-
1996
- 1996-08-14 DE DE19632772A patent/DE19632772A1/de not_active Withdrawn
-
1997
- 1997-07-29 WO PCT/EP1997/004105 patent/WO1998006740A1/de not_active Application Discontinuation
- 1997-07-29 BR BR9711134A patent/BR9711134A/pt not_active IP Right Cessation
- 1997-07-29 HU HU0001796A patent/HUP0001796A3/hu unknown
- 1997-07-29 KR KR1019997001284A patent/KR20000030004A/ko not_active Application Discontinuation
- 1997-07-29 DE DE59702414T patent/DE59702414D1/de not_active Expired - Fee Related
- 1997-07-29 JP JP10509341A patent/JP2000517300A/ja active Pending
- 1997-07-29 AU AU37715/97A patent/AU717692B2/en not_active Ceased
- 1997-07-29 CZ CZ99311A patent/CZ31199A3/cs unknown
- 1997-07-29 ES ES97934552T patent/ES2151741T3/es not_active Expired - Lifetime
- 1997-07-29 US US09/242,126 patent/US6440937B1/en not_active Expired - Fee Related
- 1997-07-29 CN CN97198721A patent/CN1233256A/zh active Pending
- 1997-07-29 AT AT97934552T patent/ATE196637T1/de not_active IP Right Cessation
- 1997-07-29 EP EP97934552A patent/EP0918792B1/de not_active Expired - Lifetime
- 1997-07-29 CA CA002263344A patent/CA2263344A1/en not_active Abandoned
- 1997-07-29 IL IL12823197A patent/IL128231A0/xx unknown
- 1997-08-08 TW TW086111384A patent/TW442471B/zh active
- 1997-08-13 ZA ZA977240A patent/ZA977240B/xx unknown
-
1999
- 1999-02-12 NO NO990667A patent/NO990667L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0918792A1 (de) | 1999-06-02 |
| NO990667D0 (no) | 1999-02-12 |
| CA2263344A1 (en) | 1998-02-19 |
| AU717692B2 (en) | 2000-03-30 |
| AU3771597A (en) | 1998-03-06 |
| ATE196637T1 (de) | 2000-10-15 |
| CN1233256A (zh) | 1999-10-27 |
| WO1998006740A1 (de) | 1998-02-19 |
| JP2000517300A (ja) | 2000-12-26 |
| ZA977240B (en) | 1999-02-15 |
| CZ31199A3 (cs) | 1999-06-16 |
| EP0918792B1 (de) | 2000-09-27 |
| DE59702414D1 (de) | 2000-11-02 |
| IL128231A0 (en) | 1999-11-30 |
| TW442471B (en) | 2001-06-23 |
| BR9711134A (pt) | 1999-08-17 |
| DE19632772A1 (de) | 1998-02-19 |
| HUP0001796A2 (hu) | 2000-11-28 |
| KR20000030004A (ko) | 2000-05-25 |
| ES2151741T3 (es) | 2001-01-01 |
| US6440937B1 (en) | 2002-08-27 |
| NO990667L (no) | 1999-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001796A3 (en) | Dipeptide benzamidine as a kininogenase inhibitor and pharmaceutical compositions containing them | |
| HUP9900964A3 (en) | Protease inhibitors and pharmaceutical compositions containing these compounds | |
| HUP9800263A3 (en) | Novel dipeptide amidines as thrombin inhibitors | |
| IL109867A0 (en) | alpha-heteroaryloxymethyl ketones as interleukin -1beta protease inhibitors and pharmaceutical compositions containing them | |
| HUP0104768A3 (en) | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same | |
| HUP9702035A3 (en) | Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them | |
| HUP9702036A3 (en) | Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them | |
| HUP9702034A3 (en) | Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them | |
| IL128664A (en) | Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them | |
| HUP9802202A3 (en) | Peptides having cell adhesion inhibitor effect and pharmaceutical compositions containing them | |
| AP9701054A0 (en) | Inhibitors of cycteine protease | |
| HUP0101598A3 (en) | Prodrugs of aspartyl protease inhibitors and medicaments containing them | |
| HUP0100669A3 (en) | Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof | |
| HUP0100186A3 (en) | Compounds as lactam metalloprotease inhibitors and pharmaceutical compositions containing them | |
| IL109503A0 (en) | Hiv protease inhibitors and pharmaceutical compositions containing them | |
| IL119466A0 (en) | Thrombin inhibitors their preparation and pharmaceutical compositions containing them | |
| IL114015A0 (en) | Inhibitors of interleukin-1beta converting enzyme and pharmaceutical compositions containing the same | |
| IL130102A0 (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors pharmaceutical compositions containing the same and processes for preparing the same | |
| HUP0103806A3 (en) | Serine protease inhibitor and pharmaceutical compositions containing them | |
| HUP0104500A3 (en) | Thrombin inhibitor dipeptide derivatives and their use | |
| IL122813A0 (en) | Thrombin inhibitors their preparation and use | |
| IL120311A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them | |
| IL127325A0 (en) | Amino acid derivatives and their use as thrombin inhibitors | |
| HUP0002951A3 (en) | Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them | |
| IL120310A0 (en) | Serine protease inhibitors and pharmaceutical compositions containing them |